13F-HR filed by Frazier Life Sciences Management, L.P.
Frazier Life Sciences Management, L.P. filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 47 holding rows worth $2,187,908,599.
- Accession
- 0001892134-25-000005
- Filer
- CIK 1892134
- Filed
- 2025-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 47 entries on the cover page, a total value of $2,187,908,599 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,187,908,599 with VALUE read as dollars as filed, 13F file number 028-22504. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 16,116,418 | $329,903,076 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 6,795,121 | $306,120,201 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 3,457,850 | $219,538,897 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 8,785,284 | $137,401,842 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 3,800,457 | $131,381,798 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 688,460 | $124,129,338 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 1,754,834 | $87,109,960 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,397,527 | $71,790,962 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 10,259,409 | $64,531,683 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 10,109,279 | $63,385,179 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 4,887,867 | $56,405,985 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 4,129,001 | $45,460,301 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 5,985,347 | $44,171,861 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 678,760 | $35,953,917 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 499,159 | $35,664,911 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 997,455 | $35,270,009 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 11,462,301 | $31,750,574 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 1,069,854 | $31,346,722 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 22,575,851 | $30,928,916 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 658,715 | $23,852,070 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 133,333 | $20,781,281 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 539,405 | $20,367,933 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 601,129 | $19,849,280 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 690,012 | $19,313,436 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 770,000 | $18,857,300 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 7,819,863 | $17,594,692 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 373,100 | $15,703,779 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 525,000 | $15,498,000 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 10,617,062 | $15,394,740 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,443,341 | $15,097,347 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 350,000 | $12,649,000 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 301,170 | $8,935,714 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,410,193 | $7,868,877 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 470,338 | $7,812,314 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 1,953,547 | $7,540,691 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,079,025 | $7,197,097 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 4,623,324 | $7,166,152 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 583,327 | $5,984,935 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 3,868,750 | $5,648,375 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 1,247,911 | $5,628,079 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 936,576 | $5,610,090 | dollars as filed | |
| ADVERUM BIOTECHNOLOGIES INC | 00773U207 | COM NEW | 1,069,244 | $4,672,596 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 500,333 | $4,497,994 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 3,175,665 | $4,033,095 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 955,515 | $3,315,637 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,148,591 | $3,239,027 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 5,993,579 | $1,552,936 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001892134-25-000005 | this filing | 2025-05-15 | acceptance time not in the bulk data set |